Dima Qato, PharmD, MPH, PhD is an invited panelist for the plenary discussion on How is USC Engaging in the Work of Global Health? at the 2025 USC Global Health Symposium hosted by USC Institute on Inequalities in Global Health…Continue Reading Dr. Qato an invited panelist for 2025 USC Global Health Symposium
By Liz BrodyPublished for Oprah daily on Jan 28, 2025 (…) Of course, that’s still out of reach for many people. Qato’s research in JAMA Health Forum hits on the hard truth of the inequity playing out. While obesity disproportionately affects those on Medicare and Medicaid, in 2023, nearly 90 percent of Wegovy prescription fills…Continue Reading We’re 60 Weeks Into the Weight Loss Drug Revolution. Now What?
By Nada Hassanein for Stateline on January 17, 2025 Independent drugstores are closing at an alarming rate — about one a day in 2023 — squeezed by the huge companies that reimburse pharmacies for costly medications. But with each closure, a community loses more than another place where they can buy medicine. Experts say independent…Continue Reading Independent pharmacies know their communities. But many are struggling to stay open
Dima Qato, PharmD, MPH, PhD presented on pharmacy closures and policy implications at Academy of Managed Care Pharmacy (AMCP) Foundation Research Symposium, “Access, Affordability and Adherence: Addressing Disparities in Medication Use,” December 3-4….Continue Reading
Dima M. Qato, PharmD, MPH, PhD was quoted in AARP about the importance of signing up for a health plan that provides more pharmacy options….Continue Reading
The New Yorker (“Is Contraception Under Attack?”) cited Qato’s study finding that oral contraceptive prescriptions had fallen in states with restrictive abortion policies….Continue Reading
‘Unprecedented’ number of pharmacies shuttered in recent years, putting Black and Latino communities at risk By Helen Jeong and Ted Chen for NBC Los Angeles, December 5, 2024 Black and Latino communities are facing growing risks of losing access to medical services as an unprecedented amount of pharmacies across the U.S. closed in the recent…Continue Reading ‘Unprecedented’ number of pharmacies shuttered in recent years, putting Black and Latino communities at risk
Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult By Stephanie Brown for Verywellhealth, December 13, 2024 Semaglutide has been approved by the Food and Drug Administration (FDA) for type 2 diabetes management, weight loss, and heart disease prevention. About 137 million Americans—more than half of all adults—are eligible…Continue Reading Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult
